Nav: Home

One third of rheumatoid arthritis patients experience sexual dysfunction

June 10, 2016

London, United Kingdom, June 10, 2016: The results of a study presented today at the European League Against Rheumatism Annual Congress (EULAR 2016) showed that sexual dysfunction is present in more than one-third of patients with rheumatoid arthritis (RA) who are still sexually active, both men and women. A variety of difficulties may affect RA patients, including lack of libido, painful intercourse, orgasmic dysfunction, premature ejaculation and a non-satisfactory sexual life.

"Sexuality is an important dimension of an individual's personality, and sexual problems can have a seriously detrimental impact on a couple's relationship," said lead author Dr Pedro Santos-Moreno of the Biomab, Centre for Rheumatoid Arthritis, Bogota, Colombia. "It is therefore rather surprising that, up until now, very little quality research on sexual disturbances in RA patients has been published in the literature, bearing in mind how common the problems are," he added.

Many factors may influence the prevalence and worsening of these sexual disturbances; however, the relationship between having a sexual disturbance and RA disease activity was not statistically significant; the problems themselves do not affect activity of the disease. However, there is a relationship between not being sexually active and the presence of disease activity.

This study explored three different type of factors - precipitating, predisposing and maintenance -- that may influence the prevalence and worsening of sexual disturbances in RA patients, as well as their relationship with disease activity.

Precipitating factors for sexual dysfunction in women and men with RA respectively included infidelity (33% and 6%), insecurity in a sexual role (32% and 16%), and biological or physical causes (17% and 3%). The range of predisposing factors in women and men respectively were related to image changes (14% and 21%), infidelity (13% and 7%), anxiety (2% and 2%) and loss of attraction (1.4% and 10%).

Reported factors felt to be responsible for sexual disturbances continuing in women and men respectively (so-called maintenance factors) included biological causes (11% and 15%), infidelity (9% and 4%), general alteration of the couple's relationship (9% and 19%), partner's sexual dysfunction (3% and 0.8%), and depression/anxiety (1.9% and 5%).

The relationship between these various precipitating, predisposing or maintenance factors and disease activity was also not statistically significant.

Patients in this study were all attending a specialised RA clinic, with information collected through semi-structured interviews. From a population of 1,298 RA patients, with an average age of 55 years old, 80% were women, of whom 40% reported no sexual activity. Just under one-third of the men with RA in this study also reported no sexual activity.

Abstract Number: OP0308-HPR
-end-
NOTES TO EDITORS:

For further information on this study, or to request an interview with the study lead, please do not hesitate to contact the EULAR congress

Press Office in the London Suite at ExCel London during EULAR 2016 or on:

Email: eularpressoffice@cohnwolfe.com

Onsite tel: +44 (0) 7725 915 492 / +44 (0) 7786 171 476

Twitter: @EULAR_Press

Youtube: Eular Pressoffice

About EULAR

The European League Against Rheumatism (EULAR) is an umbrella organisation which represents scientific societies, health professional associations and organisations for people with Rheumatic Musculoskeletal Diseases (RMD) throughout Europe.

EULAR aims to promote, stimulate and support the research, prevention, and treatment of RMD and the rehabilitation of those it affects.

EULAR underlines the importance of combating rheumatic diseases not only by medical means, but also through a wider context of care for rheumatic patients and a thorough understanding of their social and other needs. EULAR is supported in this mission by its 45 scientific member societies, 36 PARE (People with Arthritis/Rheumatism in Europe) organisations, 22 HPR (Health Professionals in Rheumatology) associations and 23 corporate members.

The EULAR Annual European Congress of Rheumatology is the foremost international medical meeting announcing the latest research on rheumatic and musculoskeletal diseases. EULAR 2016 is expected to attract over 14,000 delegates from around 120 countries. Most if not all professions working in the vast field of RMD will be represented.

To find out more about the activities of EULAR, visit: http://www.eular.org

References

1. EULAR 2016; London: Abstract OP0308-HPR

European League Against Rheumatism

Related Rheumatoid Arthritis Articles:

Study examines opioid use in patients with rheumatoid arthritis
A new analysis indicates that the use of opioid pain medications in older US rheumatoid arthritis patients peaked in 2010 and is now declining slightly.
Studies examine rheumatoid arthritis patients' prognosis
What's the long-term outlook for today's patients with early rheumatoid arthritis?
Obesity may influence rheumatoid arthritis blood tests
New research reveals that in women, obesity may influence blood tests used to diagnose and monitor rheumatoid arthritis.
New tool for prognosis and choice of therapy for rheumatoid arthritis
In rheumatoid arthritis, antibodies are formed that affect the inflammation in the joints.
The promise of precision medicine for rheumatoid arthritis
In a new study, a Yale-led research team identified the mechanism of a gene that raises the risk of severe rheumatoid arthritis in susceptible individuals.
Immunotherapy reduces cardiovascular risk in rheumatoid arthritis
Weight loss from bariatric surgery appears to reverse the premature aging associated with obesity, according to research presented today at Frontiers in CardioVascular Biology 2016.
Osteoarthritis just as severe as rheumatoid arthritis
Rheumatologists more likely to underestimate clinical status of their OA patients than their RA patients
Serotonin deficiency implicated in rheumatoid arthritis
For the first time, serotonin (5-hydroxytryptamine, 5-HT) has been directly implicated in the pathophysiology of rheumatoid arthritis (RA).
Link between mood, pain in rheumatoid arthritis patients
Depressive symptoms and mood in the moment may predict momentary pain among rheumatoid arthritis patients, according to Penn State researchers.
Inflammation in the mouth and joints in rheumatoid arthritis
Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher Sheila Arvikar, Massachusetts General Hospital, Boston, USA, will present a study titled 'Inflammation in the Mouth and Joints in Rheumatoid Arthritis.' The IADR General Session is being held in conjunction with the 44th Annual Meeting of the American Association for Dental Research and the 39th Annual Meeting of the Canadian Association for Dental Research.

Related Rheumatoid Arthritis Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...